Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Merck & Company Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Merck & Company Inc. May 26, 202693.4%
-
Morgan Stanley May 14, 202697.4%
-
Merck & Company Inc. May 27, 202592.6%
-
Morgan Stanley May 23, 202497.2%
-
Merck & Company Inc. May 23, 202392.6%
-
Morgan Stanley May 19, 202397.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 1, 2026 | Morgan Stanley | Grant or award | +1,310 | — | — |
| Jun 1, 2026 | Morgan Stanley | Grant or award | +512 | $209.96 | $107,500 |
| Dec 1, 2025 | Morgan Stanley | Grant or award | +637 | $168.76 | $107,502 |
| Jun 1, 2025 | Morgan Stanley | Grant or award | +2,155 | — | — |
| Jun 1, 2025 | Morgan Stanley | Grant or award | +843 | $127.58 | $107,498 |
| Dec 1, 2024 | Morgan Stanley | Grant or award | +757 | $132.04 | $100,003 |
| Jun 1, 2024 | Morgan Stanley | Grant or award | +2,675 | — | — |
| Jun 1, 2024 | Morgan Stanley | Grant or award | +1,029 | $97.19 | $100,005 |
| Dec 1, 2023 | Morgan Stanley | Grant or award | +1,247 | $80.20 | $99,994 |
| Jun 1, 2023 | Morgan Stanley | Grant or award | +3,168 | — | — |
| Jun 1, 2023 | Morgan Stanley | Grant or award | +1,218 | $82.08 | $100,006 |
| May 3, 2023 | Morgan Stanley | Open-market sale | −4,535 | $87.11 | $395,044 |
Questions about Thomas H. Glocer
What boards is Thomas H. Glocer on?
Thomas H. Glocer sits on the boards of Merck & Company Inc. and Morgan Stanley.
How long has Thomas H. Glocer served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.